Rheumatology Journal Club Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and Division of Rheumatology

TOPIC Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

Speaker: John Zawidniak, MD Date: January 10, 2018 Time: 5:30 pm -6:00 pm Location: Administrative Service Building (ASB) 3rd fl rheumatology conf room D3240

Target Audience: rheumatologists

Learning Objectives: Participants will (be able to): 1. Discuss previous studies that have been performed with different results regarding rituximab for systemic lupus erythematosus

2. Discuss findings from the BILAG biologics register in regards to treatment of refractory Systemic lupus erythematosus

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Connecticut School of Medicine designates this live activity for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Neither the activity director, planning committee members, nor the speaker, Dr. Zawidniak have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Dr.Zawidniak will be discussing an off-labeled use of Rituximab

This CME activity has no commercial support associated with it.

Evaluations: Participants are required to complete an electronic evaluation in order to obtain CME Credits. An email from http://MyEvaluations.com with instructions will be sent to participants. Please complete the evaluation within one week of receiving the email.

If you do not receive an evaluation assignment from http://MyEvaluations.com within 10 business days of this activity, please contact the Department that hosted this activity (indicated above) to ensure that your http://MyEvaluations.com account is set up and your participation in this activity was forwarded to the CME office. Please contact Dr. Lakshminarayanan for more information at 860 679 3605